Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 6/20 | 0.68 |
| ▸ | ECE1 | P42892 | 6/20 | 0.66 |
| ▸ | EDNRA | P25101 | 1/20 | 0.64 |
| ▸ | ACE | P12821 | 2/20 | 0.62 |
| ▸ | IL1RN | P18510 | 5/20 | 0.62 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.62 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.57 |
| ▸ | MMP8 | P22894 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29769026 | 0.99 | ERAP2 (0.69) | ERAP2ECE1EDNRAACEIL1RN | |
| SCHEMBL30051527 | 0.97 | ECE1 (0.64) | ERAP2ECE1EDNRAACEIL1RN | |
| SCHEMBL29379405 | 0.96 | ERAP2 (0.64) | ERAP2ECE1EDNRAACEIL1RN | |
| SCHEMBL30051826 | 0.95 | ACE (0.68) | ERAP2ECE1ACE | |
| SCHEMBL7397641 | 0.93 | ACE (0.71) | ECE1ACE | |
| SCHEMBL5481232 | 0.93 | ACE (0.71) | ECE1ACE | |
| SCHEMBL3512696 | 0.93 | ACE (0.71) | ECE1ACE | |
| SCHEMBL8725890 | 0.93 | ACE (0.71) | ECE1ACE | |
| SCHEMBL30052487 | 0.91 | ACE (0.63) | ERAP2ECE1ACE | |
| SCHEMBL30053126 | 0.91 | ACE (0.63) | ERAP2ECE1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219805-B1 | ANTIBODY LIBRARIES | ADIMAB LLC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-20240352625-A1 | LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-10-24 | — | — | US | disclosed |
| US-11926926-B2 | Libraries of genetic packages comprising novel HC CDR3 designs | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-03-12 | — | — | US | disclosed |
| US-20230340697-A1 | LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-26 | — | — | US | disclosed |
| EP-4219805-A1 | ANTIBODY LIBRARIES | Adimab, LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11598024-B2 | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-03-07 | — | — | US | disclosed |